Efficacy and safety of etanercept 50 mg twice a week in patients with rheumatoid arthritis who had a suboptimal response to etanercept 50 mg once a week: Results of a multicenter, randomized, double-blind, active drug-controlled study
Michael E. Weinblatt, Michael H. Schiff, Eric M. Ruderman, Clifton O. Bingham, Juan Li, James Louie, Daniel E. Furst
Dive into the research topics of 'Efficacy and safety of etanercept 50 mg twice a week in patients with rheumatoid arthritis who had a suboptimal response to etanercept 50 mg once a week: Results of a multicenter, randomized, double-blind, active drug-controlled study'. Together they form a unique fingerprint.